annual CFO:
-$142.11M+$18.85M(+11.71%)Summary
- As of today (September 16, 2025), CNTA annual cash flow from operations is -$142.11 million, with the most recent change of +$18.85 million (+11.71%) on December 31, 2024.
- During the last 3 years, CNTA annual CFO has fallen by -$5.97 million (-4.39%).
Performance
CNTA Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$22.92M+$34.55M(+60.12%)Summary
- As of today (September 16, 2025), CNTA quarterly cash flow from operations is -$22.92 million, with the most recent change of +$34.55 million (+60.12%) on June 1, 2025.
- Over the past year, CNTA quarterly CFO has increased by +$17.71 million (+43.59%).
- CNTA quarterly CFO is now -80.94% below its all-time high of -$12.67 million, reached on March 31, 2021.
Performance
CNTA quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$144.61M+$17.71M(+10.91%)Summary
- As of today (September 16, 2025), CNTA TTM cash flow from operations is -$144.61 million, with the most recent change of +$17.71 million (+10.91%) on June 1, 2025.
- Over the past year, CNTA TTM CFO has increased by +$1.76 million (+1.21%).
- CNTA TTM CFO is now -1041.72% below its all-time high of -$12.67 million, reached on March 31, 2021.
Performance
CNTA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CNTA Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +11.7% | +43.6% | +1.2% |
3 y3 years | -4.4% | +61.5% | +27.4% |
5 y5 years | -2339.7% | - | - |
CNTA Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -4.4% | +29.1% | -5.1% | +61.5% | -10.6% | +29.1% |
5 y | 5-year | <-9999.0% | +29.1% | -80.9% | +61.5% | -1041.7% | +29.1% |
alltime | all time | <-9999.0% | +29.1% | -80.9% | +61.5% | -1041.7% | +29.1% |
CNTA Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$22.92M(-60.1%) | -$144.61M(-10.9%) |
Mar 2025 | - | -$57.47M(+35.5%) | -$162.32M(+14.2%) |
Dec 2024 | -$142.11M(-11.7%) | -$42.41M(+94.5%) | -$142.11M(+8.6%) |
Sep 2024 | - | -$21.81M(-46.3%) | -$130.80M(-10.6%) |
Jun 2024 | - | -$40.63M(+9.0%) | -$146.37M(-2.4%) |
Mar 2024 | - | -$37.26M(+19.8%) | -$149.96M(-6.8%) |
Dec 2023 | -$160.96M(-19.7%) | -$31.10M(-16.8%) | -$160.96M(-11.8%) |
Sep 2023 | - | -$37.38M(-15.4%) | -$182.58M(-0.5%) |
Jun 2023 | - | -$44.21M(-8.4%) | -$183.42M(-7.7%) |
Mar 2023 | - | -$48.27M(-8.4%) | -$198.70M(-0.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | -$200.42M(+47.2%) | -$52.71M(+37.9%) | -$200.42M(-1.8%) |
Sep 2022 | - | -$38.22M(-35.8%) | -$204.00M(+2.5%) |
Jun 2022 | - | -$59.50M(+19.0%) | -$199.10M(+14.8%) |
Mar 2022 | - | -$49.99M(-11.2%) | -$173.47M(+27.4%) |
Dec 2021 | -$136.14M(<-9900.0%) | -$56.29M(+68.9%) | -$136.14M(+70.5%) |
Sep 2021 | - | -$33.32M(-1.6%) | -$79.85M(+71.6%) |
Jun 2021 | - | -$33.87M(+167.4%) | -$46.53M(+267.4%) |
Mar 2021 | - | -$12.67M | -$12.67M |
Dec 2020 | $0.00(-100.0%) | - | - |
Dec 2019 | -$5.83M | - | - |
FAQ
- What is Centessa Pharmaceuticals plc annual cash flow from operations?
- What is the all time high annual CFO for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc annual CFO year-on-year change?
- What is Centessa Pharmaceuticals plc quarterly cash flow from operations?
- What is the all time high quarterly CFO for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc quarterly CFO year-on-year change?
- What is Centessa Pharmaceuticals plc TTM cash flow from operations?
- What is the all time high TTM CFO for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc TTM CFO year-on-year change?
What is Centessa Pharmaceuticals plc annual cash flow from operations?
The current annual CFO of CNTA is -$142.11M
What is the all time high annual CFO for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high annual cash flow from operations is $0.00
What is Centessa Pharmaceuticals plc annual CFO year-on-year change?
Over the past year, CNTA annual cash flow from operations has changed by +$18.85M (+11.71%)
What is Centessa Pharmaceuticals plc quarterly cash flow from operations?
The current quarterly CFO of CNTA is -$22.92M
What is the all time high quarterly CFO for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high quarterly cash flow from operations is -$12.67M
What is Centessa Pharmaceuticals plc quarterly CFO year-on-year change?
Over the past year, CNTA quarterly cash flow from operations has changed by +$17.71M (+43.59%)
What is Centessa Pharmaceuticals plc TTM cash flow from operations?
The current TTM CFO of CNTA is -$144.61M
What is the all time high TTM CFO for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high TTM cash flow from operations is -$12.67M
What is Centessa Pharmaceuticals plc TTM CFO year-on-year change?
Over the past year, CNTA TTM cash flow from operations has changed by +$1.76M (+1.21%)